Accession Number:

AD1000593

Title:

Novel Therapeutic Targets to Inhibit Tumor Microenvironment Induced Castration-resistant Prostate Cancer

Descriptive Note:

Technical Report,15 Sep 2014,14 Sep 2015

Corporate Author:

Baylor College of Medicine Houston United States

Personal Author(s):

Report Date:

2015-10-01

Pagination or Media Count:

11.0

Abstract:

We previously demonstrated that stromal TGF-beta signaling induced the expression of several AR targets as well as MAPK4 in PCa LNCaP cells, and that MAPK4 induced ligand-independent AR activation in PCa cells. Therefore, we proposed to use in vitro PCastroma co-culture models and in vivo xenograft models to test our hypothesis on stromal TGF-beta signaling inducing MAPK4 for androgen-independent AR activation in PCa as a direct mechanism for CRPC relapse. In this second year, we have met some technical problems including altered expression of MAPK4 in the continuously cultured LNCaP cells with stable overexpression or knockdown of MAPK4. Accordingly, we have generated LNCaP cells with Dox-inducible knockdown or Doxinducible overexpression of MAPK4. We have also created HPS19I cells overexpressing the dominant negative TbetaRII. These provide key reagents for our proposed in vitro and in vivo studies. We expect to be able to finish the proposed studies at the conclusion of this award.

Subject Categories:

Distribution Statement:

APPROVED FOR PUBLIC RELEASE